inability to stand for more than a minute even supported; increased heart rate; falling over; shortness of breath; Chest pain; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: EW0187) at the age of 29 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Postural orthostatic tachycardia syndrome" (ongoing), notes: Verbatim: Postural orthostatic tachycardia syndrome, Additional Information for Other Conditions: Diagnosed at age 14; "Fibromyalgia" (ongoing), notes: Verbatim: Fibromyalgia, Additional Information for Other Conditions: Diagnosed at age 13; "Migraine" (ongoing), notes: Verbatim: Migraine, Additional Information for Other Conditions: started at age 10; "Asthma" (ongoing), notes: Verbatim: Asthma, Additional Information for Other Conditions: Diagnosed at age 4; "Suspected Epilepsy" (ongoing), notes: Verbatim: suspected epilepsy, Additional Information for Other Conditions: Has had symptoms since age 10 but it was suggested 4 years ago. She has not been able to find a doctor to diagnose this. There were no concomitant medications. Vaccination history included: Varicella vaccine (Adverse Event: contracted chicken pox twice after receiving the Varicella vaccine. The first time was mild. She got better and then had a more severe case following the vaccine), for Chicken Pox, reaction(s): "had a more severe case following the vaccine". The following information was reported: DYSSTASIA (non-serious) with onset 29Jul2021, outcome "recovered with sequelae" (30Jul2021), described as "inability to stand for more than a minute even supported"; HEART RATE INCREASED (non-serious) with onset 29Jul2021, outcome "recovering", described as "increased heart rate"; FALL (non-serious) with onset 29Jul2021, outcome "recovering", described as "falling over"; DYSPNOEA (non-serious) with onset 29Jul2021, outcome "recovering", described as "shortness of breath"; CHEST PAIN (non-serious) with onset 29Jul2021, outcome "recovering", described as "Chest pain"; FATIGUE (non-serious) with onset 29Jul2021, outcome "recovering", described as "Fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Product: Covid 19 vaccine. Caller received the first dose 3 weeks ago. She had some unusual symptoms and is still recovering. She is unable to see a doctor. She is trying to figure out if she should get the second dose. She experienced an increased heart rate, inability to stand for more than a minute even supported. That lasted 7 hours. She was falling over, had shortness of breath, chest pain and fatigue.Caller does not have a doctor. Vaccine Administered at  Facility No History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) None Additional Vaccines Administered on Same Date of the Pfizer Suspect None .Adverse Event (AE) Details: Provide the time of onset of AE(s): Adverse Event: She experienced an increased heart rate, inability to stand for more than a minute even supported. That lasted 7 hours. She was falling over, had shortness of breath, chest pain and fatigue.any AE(s) require a visit to Emergency Room No ,Physician Office  No .Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s None AE(s) following prior vaccinations None or Unknown . Adverse Event contracted chicken pox twice after receiving the Varicella vaccine. The first time was mild. She got better and then had a more severe case following the vaccine  Follow-up attempts are completed. No further information is expected.